About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 117 record(s)
Req # A-2021-000947
Adverse Drug Reactions (ADRs) for NITROLINGUAL SPRAY. Report numbers: E2B_03761470, E2B_03879484, E2B_04084422.Organization: Health Canada
July 2022
Req # A-2021-001045
Adverse Drug Reactions (ADRs) for ZOPICLONE. Report numbers: E2B_03811824, E2B_03841105, E2B_03840754.Organization: Health Canada
July 2022
Req # A-2021-001272
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-108525-567.Organization: Health Canada
July 2022
Req # A-2021-001724
Adverse Drug Reaction (ADR) for METOLAZONE. Report number: E2B_04308431.Organization: Health Canada
July 2022
Req # A-2021-001757
Adverse Drug Reaction (ADR). Report number: E2B_04715322.Organization: Health Canada
July 2022
Req # A-2021-001984
Adverse Drug Reactions (ADRs). Report numbers: E2B_00454504, 000693072, E2B_00181017, 000590850, E2B_01664814, E2B_01695306.Organization: Health Canada
July 2022
Req # A-2021-002034
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-100903-339.Organization: Health Canada
July 2022
Req # A-2021-002050
Adverse Drug Reaction (ADR) for HYOSCINE BUTYLBROMIDE. Report number: 973791.Organization: Health Canada
July 2022
Req # A-2021-002054
Adverse Drug Reactions (ADRs) for METFORMIN HYDROCHLORIDE. Report numbers: E2B_04778420, 000977759.Organization: Health Canada
July 2022
Req # A-2021-002060
Adverse Drug Reactions (ADRs) for VARIVAX III. Report numbers: E2B_02504551, E2B_00399116, E2B_02381693, E2B_02384381, E2B_00955709, E2B_02379141, E2B_02379145. ADRs for ZEPATIER. Report numbers: 000707230, 000709520, E2B_02051456, E2B_02191030, E2B_02261509, E2B_02453155.Organization: Health Canada
July 2022